Search Results - "Clinical microbiology and infection"

Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study by Pasomsub, E., Watcharananan, S.P., Boonyawat, K., Janchompoo, P., Wongtabtim, G., Suksuwan, W., Sungkanuparph, S., Phuphuakrat, A.

“…Amid the increasing number of pandemic coronavirus disease 2019 (COVID-19) cases, there is a need for a quick and easy method to obtain a non-invasive sample…”
Get full text

Viable SARS-CoV-2 in various specimens from COVID-19 patients by Jeong, Hye Won, Kim, Se-Mi, Kim, Hee-Sung, Kim, Young-Il, Kim, Jun Hyoung, Cho, Jun Yeon, Kim, Sun-hyung, Kang, Hyeran, Kim, Seong-Gyu, Park, Su-Jin, Kim, Eun-Ha, Choi, Young Ki

“…The aim was to determine whether various clinical specimens obtained from COVID-19 patients contain the infectious virus. To demonstrate whether various…”
Get full text

ESCMID guideline: diagnosis and treatment of acute bacterial meningitis by van de Beek, D., Cabellos, C., Dzupova, O., Esposito, S., Klein, M., Kloek, A.T., Leib, S.L., Mourvillier, B., Ostergaard, C., Pagliano, P., Pfister, H.W., Read, R.C., Sipahi, O. Resat, Brouwer, M.C.

Get full text

Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs by Van Elslande, Jan, Decru, Bram, Jonckheere, Stijn, Van Wijngaerden, Eric, Houben, Els, Vandecandelaere, Patricia, Indevuyst, Christophe, Depypere, Melissa, Desmet, Stefanie, André, Emmanuel, Van Ranst, Marc, Lagrou, Katrien, Vermeersch, Pieter

“…The aim was to determine the antibody response against SARS-CoV-2 spike protein and nucleoprotein using four automated immunoassays and three ELISAs for the…”
Get full text

Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status by Eyre, David W., Lumley, Sheila F., Wei, Jia, Cox, Stuart, James, Tim, Justice, Anita, Jesuthasan, Gerald, O'Donnell, Denise, Howarth, Alison, Hatch, Stephanie B., Marsden, Brian D., Jones, E. Yvonne, Stuart, David I., Ebner, Daniel, Hoosdally, Sarah, Crook, Derrick W., Peto, Tim E.A., Walker, Timothy M., Stoesser, Nicole E., Matthews, Philippa C., Pouwels, Koen B., Walker, A. Sarah, Jeffery, Katie

“…We investigated determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-spike IgG responses in healthcare workers (HCWs) following…”
Get full text

Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort by Ghosn, Jade, Piroth, Lionel, Epaulard, Olivier, Le Turnier, Paul, Mentré, France, Bachelet, Delphine, Laouénan, Cédric

“…Persistent COVID-19 symptoms have been reported up to 3 months after hospital discharge. Little is known on the frequency and the nature of persistent symptoms…”
Get full text

Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability by Hirose, Ryohei, Itoh, Yoshito, Ikegaya, Hiroshi, Miyazaki, Hajime, Watanabe, Naoto, Yoshida, Takuma, Bandou, Risa, Daidoji, Tomo, Nakaya, Takaaki

“…The increased infectivity and transmissibility of SARS-CoV-2 variants of concern (VOCs) could cause significant human and economic damage. Hence, understanding…”
Get full text

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis by Langford, Bradley J., So, Miranda, Raybardhan, Sumit, Leung, Valerie, Westwood, Duncan, MacFadden, Derek R., Soucy, Jean-Paul R., Daneman, Nick

“…Bacterial co-pathogens are commonly identified in viral respiratory infections and are important causes of morbidity and mortality. The prevalence of bacterial…”
Get full text

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review by Fiolet, Thibault, Kherabi, Yousra, MacDonald, Conor-James, Ghosn, Jade, Peiffer-Smadja, Nathan

“…Vaccines are critical cost-effective tools to control the coronavirus disease 2019 (COVID-19) pandemic. However, the emergence of variants of the severe acute…”
Get full text

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) by Paul, Mical, Carrara, Elena, Retamar, Pilar, Tängdén, Thomas, Bitterman, Roni, Bonomo, Robert A., de Waele, Jan, Daikos, George L., Akova, Murat, Harbarth, Stephan, Pulcini, Celine, Garnacho-Montero, José, Seme, Katja, Tumbarello, Mario, Lindemann, Paul Christoffer, Gandra, Sumanth, Yu, Yunsong, Bassetti, Matteo, Mouton, Johan W., Tacconelli, Evelina, Rodríguez-Baño, Jesús

“…These ESCMID guidelines address the targeted antibiotic treatment of third-generation cephalosporin-resistant Enterobacterales (3GCephRE) and…”
Get full text

Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study by Garcia-Vidal, Carolina, Sanjuan, Gemma, Moreno-García, Estela, Puerta-Alcalde, Pedro, Garcia-Pouton, Nicole, Chumbita, Mariana, Fernandez-Pittol, Mariana, Pitart, Cristina, Inciarte, Alexy, Bodro, Marta, Morata, Laura, Ambrosioni, Juan, Grafia, Ignacio, Meira, Fernanda, Macaya, Irene, Cardozo, Celia, Casals, Climent, Tellez, Adrian, Castro, Pedro, Marco, Francesc, García, Felipe, Mensa, Josep, Martínez, José Antonio, Soriano, Alex, Rico, Verónica, Hernández-Meneses, Marta, Agüero, Daiana, Torres, Berta, González, Ana, de la Mora, Lorena, Rojas, Jhon, Linares, Laura, Fidalgo, Berta, Rodriguez, Natalia, Nicolas, David, Albiach, Laia, Muñoz, José, Almuedo, Alex, Camprubí, Daniel, Angeles Marcos, Ma, Cilloniz, Catia, Fernández, Sara, Nicolas, Jose M., Torres, Antoni

“…To describe the burden, epidemiology and outcomes of co-infections and superinfections occurring in hospitalized patients with coronavirus disease 2019…”
Get full text

COVID-19, SARS and MERS: are they closely related? by Petrosillo, N., Viceconte, G., Ergonul, O., Ippolito, G., Petersen, E.

“…The 2019 novel coronavirus (SARS-CoV-2) is a new human coronavirus which is spreading with epidemic features in China and other Asian countries; cases have…”
Get full text

Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis by Langford, Bradley J., So, Miranda, Raybardhan, Sumit, Leung, Valerie, Soucy, Jean-Paul R., Westwood, Duncan, Daneman, Nick, MacFadden, Derek R.

“…The proportion of patients infected with SARS-CoV-2 that are prescribed antibiotics is uncertain, and may contribute to patient harm and global antibiotic…”
Get full text

Follow-up of adults with noncritical COVID-19 two months after symptom onset by Carvalho-Schneider, Claudia, Laurent, Emeline, Lemaignen, Adrien, Beaufils, Emilie, Bourbao-Tournois, Céline, Laribi, Saïd, Flament, Thomas, Ferreira-Maldent, Nicole, Bruyère, Franck, Stefic, Karl, Gaudy-Graffin, Catherine, Grammatico-Guillon, Leslie, Bernard, Louis

“…To describe the clinical evolution and predictors of symptom persistence during 2 months' follow-up in adults with noncritical coronavirus disease 2019…”
Get full text

Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study by Xiong, Qiutang, Xu, Ming, Li, Jiao, Liu, Yinghui, Zhang, Jixiang, Xu, Yu, Dong, Weiguo

“…To describe the prevalence, nature and risk factors for the main clinical sequelae in coronavirus disease 2019 (COVID-19) survivors who have been discharged…”
Get full text

Female gender is associated with long COVID syndrome: a prospective cohort study by Bai, Francesca, Tomasoni, Daniele, Falcinella, Camilla, Barbanotti, Diletta, Castoldi, Roberto, Mulè, Giovanni, Augello, Matteo, Mondatore, Debora, Allegrini, Marina, Cona, Andrea, Tesoro, Daniele, Tagliaferri, Gianmarco, Viganò, Ottavia, Suardi, Elisa, Tincati, Camilla, Beringheli, Tomaso, Varisco, Benedetta, Battistini, Chiara Luridiana, Piscopo, Kyrie, Vegni, Elena, Tavelli, Alessandro, Terzoni, Stefano, Marchetti, Giulia, Monforte, Antonella d’Arminio

“…We explored the association between female gender and long COVID syndrome, defined as persistence of physical and/or psychological symptoms for more than…”
Get full text

Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis by Alkodaymi, Mohamad Salim, Omrani, Osama Ali, Fawzy, Nader A., Shaar, Bader Abou, Almamlouk, Raghed, Riaz, Muhammad, Obeidat, Mustafa, Obeidat, Yasin, Gerberi, Dana, Taha, Rand M., Kashour, Zakaria, Kashour, Tarek, Berbari, Elie F., Alkattan, Khaled, Tleyjeh, Imad M.

“…Post-acute coronavirus 2019 (COVID-19) syndrome is now recognized as a complex systemic disease that is associated with substantial morbidity. To estimate the…”
Get full text

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults by van Prehn, Joffrey, Reigadas, Elena, Vogelzang, Erik H., Bouza, Emilio, Hristea, Adriana, Guery, Benoit, Krutova, Marcela, Norén, Torbjorn, Allerberger, Franz, Coia, John E., Goorhuis, Abraham, van Rossen, Tessel M., Ooijevaar, Rogier E., Burns, Karen, Scharvik Olesen, Bente R., Tschudin-Sutter, Sarah, Wilcox, Mark H., Vehreschild, Maria J.G.T., Fitzpatrick, Fidelma, Kuijper, Ed J.

“…In 2009, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published the first treatment guidance document for Clostridioides…”
Get full text

Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting by Hughes, S., Troise, O., Donaldson, H., Mughal, N., Moore, L.S.P.

“…To investigate the incidence of bacterial and fungal coinfection of hospitalized patients with confirmed severe acute respiratory syndrome coronavirus 2…”
Get full text

Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China by Zhang, J., Wang, X., Jia, X., Li, J., Hu, K., Chen, G., Wei, J., Gong, Z., Zhou, C., Yu, H., Yu, M., Lei, H., Cheng, F., Zhang, B., Xu, Y., Wang, G., Dong, W.

“…In December 2019, coronavirus disease (COVID-19) emerged in Wuhan. However, the characteristics and risk factors associated with disease severity,…”
Get full text